Search by what decides feasibility
Audience, geography, incidence, specialization and supply model in one search, instead of scrolling a membership list or emailing one supplier at a time.
Use cases · Open Network
For healthcare and specialist teams this is where the work starts, and for everyone else it is the brief they had to decline. Rare cohorts are scattered thin across dozens of suppliers, so the buyer who asks only their usual three gets told “not feasible” about people who demonstrably exist.
Three products, one job
All three work alone. Which one you reach for first depends on who you are and what is breaking.
Rheumatology nurses in tier-2 cities. CFOs at sub-500-employee firms. Owners of one specific device. None of these cohorts live inside a single panel. They sit in ones and twos across dozens of suppliers, most of whom you have never had a reason to call.
So the brief comes back declined, and the reason given is feasibility when the real reason is roster size. The audience was always reachable. It was never reachable from three phone numbers.
The usual fix makes a different trade. A marketplace buys reach by blending supply and taking the names off it, which works right up until quality slips and there is no named source to hold accountable for it.
Rheumatology nurses · tier-2 cities
Quoted: not feasibleSupplier A
14
Supplier B
9
Supplier C
4
Supplier D
22
Supplier E
17
Supplier F
11
Supplier G
8
Illustrative distribution. No single supplier closes the cohort. Four of them together do, and three of those four were never on the list the feasibility answer was based on.
The Open Network is a structured directory of online sample suppliers, searchable by audience, geography, specialization and supply model, so the suppliers who hold a rare cohort are findable the moment your own roster is not enough.
Audience, geography, incidence, specialization and supply model in one search, instead of scrolling a membership list or emailing one supplier at a time.
Every supplier is listed by name with their capabilities attached. You know exactly who you are approaching, and nobody is folded into an anonymous pool.
Company, audience, geography, supply model, specializations, technology and quality approach, structured identically, so you compare fit rather than decipher ten capability decks.
Profile information is supplier-provided and marked as such, with a last-updated date. There are no public scores or rankings: you decide who is relevant to your brief.
SoftSight takes no commission, placement fee or margin on anything the network leads to. You approach suppliers directly, and the terms stay between you and them.
Searching the network discloses nothing. Your studies, clients and audiences reach a supplier only when you choose to contact them.
Every profile is supplier-provided and labelled as such, with a last-updated date, so you always know what you are reading. If you field sample and want to be in it, the supplier application takes about twenty minutes and is read by a person.
One problem, felt differently depending on where you sit. An agency meets it as a brief it has to decline, a specialist team as an audience that exists nowhere in one place, an insights lead as a methodology they will have to defend.
A study needs a low-incidence specialist cohort no single panel can close. Search the network for every supplier who says they can reach part of it, and a declined brief becomes a winnable one without you running a discovery project first.
Rheumatology nurses in tier-2 cities, or a rare-condition patient cohort, exist in no single panel. Find the named suppliers who each hold a part of the population, so the study happens rather than getting quoted as impossible.
A multi-market tracker needs consistent supply across forty countries, or across B2B categories thin enough that each one is its own sourcing exercise. Instead of dozens of parallel discovery conversations, the network is one entry point to reach.
A solo practitioner's supplier contacts cap what they can field, and cold-sourcing a new supplier per study is not a realistic use of one person's week. The directory is reach you do not have to go and build first.
Finding a new supplier mid-field usually means starting the search from scratch. Here the structured profiles are already there, so the next time a study needs someone new, the shortlist takes an afternoon rather than a week of emails.
An insights team commissioning reputation-sensitive work needs to know exactly which suppliers the sample came from. Named suppliers, compared on the same terms and approached directly, keep the methodology defensible in front of regulators, medical reviewers or the board.
The outcome
Feasibility becomes a network question rather than a “which three suppliers do I happen to know” question. You still choose who to work with, you still negotiate your own rates, and the relationship you form is yours to keep, because nothing sits between your price and the supplier’s invoice.
Finding six named suppliers who hold the cohort is progress right up to the moment you have to send six RFQs, compare six quote formats, negotiate six rates and reconcile six invoices. That coordination is what FieldworkOS takes off the desk.
Together they cover sourcing a study, running it, and protecting what comes back. Nothing here has to be adopted in order.
| If you are | Start with | Because |
|---|---|---|
| Client-side insights | SurveyGuard | Your name is on the data's integrity. |
| Full-service agency | FieldworkOS | Coordination is your daily bottleneck. |
| Independent researcher | FieldworkOS | It is the operations team you do not have. |
| Sample supplier | FieldworkOS | Your partner layer needs a system. |
| Healthcare / specialist | Open Network | Reaching the audience is the hard part. |
Want to see all three on one study rather than product by product? The hard-to-reach sample walkthrough follows a single German healthcare study through six steps, from the shortfall to the reconciled invoice.
The fastest way to judge network reach is against an audience you already failed to source. Tell us the cohort and the market, and we will walk the sourcing question through with you.